Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Endothelix is a medical technology company specializing in the non-invasive assessment of cardiovascular health through endothelial function testing. The company's flagship product, Vendys, utilizes Digital Thermal Monitoring (DTM) to measure the reactivity of the microvascular system, providing a surrogate marker for coronary artery health. By identifying endothelial dysfunction early, Endothelix aims to improve risk stratification for heart disease, diabetes, and other metabolic conditions. The technology is designed for use in clinical settings to monitor the effectiveness of lifestyle interventions and pharmacological treatments on vascular health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Endothelix.